We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Bioprogress | LSE:BPRG | London | Ordinary Share | GB0032681628 | ORD 1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 50.00 | 0.00 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 50.00 | GBX |
Bioprogress (BPRG) Share Charts1 Year Bioprogress Chart |
|
1 Month Bioprogress Chart |
Intraday Bioprogress Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 10/4/2011 | 17:00 | Bioprogress BPRG - Serious Investors Only (Moderated) | 20,082 |
| 23/9/2010 | 21:25 | Bioprogress General Discussion | 64,409 |
| 16/3/2010 | 16:20 | BioProgress - Get the Bin Bag ready? | 771 |
| 19/8/2009 | 00:55 | BIOPROGRESS - LISTING ON AIM THURSDAY 22nd MAY | 706 |
| 15/5/2009 | 01:32 | The BPRG Muppets Thread | 4,354 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 16/3/2010 16:20 by gkgdownie What's happened to this share? Is it returning to market or what? |
Posted at 30/7/2009 01:42 by dil m5 - 7 Apr'04 - 12:19 - 312 of 753Dream on guys, if this was going back to 80p, we would have seen it by now, its tried and failed. We are less than 2 weeks away from the agm its only going one way. Whether you believe in the share or not, be realistic, in the short term anyway. If you are short, you will burn badly. GET YOUR BUYING BOOTS ON AND MAKE SOME PROPER MONEY!!!!!!! Sorry m5 Regards Dil |
Posted at 30/7/2009 01:38 by dil poorold - 5 Mar'04 - 13:52 - 169 of 752yeah gmanhi, Why did you sell? If you had put your 200,000 pounds into BPRG, you'd have over 1,000,000 pounds PROFIT!!! in less than 8 months!!! Don't you research anything in which you invest??? Or do you just get off making a couple of pounds here and there and stressing yourself out??? Starting to get it guys ?????? Dil |
Posted at 12/9/2007 15:29 by rafboy Right guys and girls listen in. There will be no SCP deal announced tomorrow of that I am sure. RT has made it clear that his previous timescales should be met ie before end Oct 07 and lets face it even that could slip a bit. So don't set yourselves up for a fall on that score. As for tabwrap, well we might get a bit more info but once again no deal will be announced as yet IMHO. So what will we see. Obviously, the name change should go through on the nod. Then there will be an update of some kind but how detailed that will be is anyone's guess. We may hear about new areas for existing products or about advertising and marketing that is about to happen. The interims will be later this month but what the big boys are after is evidence of net profit and that will come at year end. The other thing they want to see is a major deal and that will have to wait for a few weeks. Anyone who is going to the AGM please ensure it is kept civil. No matter what we think of the share price or RT's share sale we should discuss these things in a civil manner. We must not get our new company off to a bad start. Hopefully we will see the share price start to rise following the name change as people take a closer look at us. So there you have it the EGM will not set the share price alight but I believe it could put a floor under the share price for good. All IMHO and regards to all. |
Posted at 12/9/2007 10:31 by aflynn I believe that the seller is also the buyer. For the minimum amount of loss it does not require a great deal of money to maintain the share in a reasonably tight band. From observation say a buy of 10000 shares has a 1 change in lifting the share price where as a sell of the same 10000 has a 1.25 change in depressing the share price Providing the mm margin is in the range of 0.25 to 0.5 then with an initial outlay of say 100 grand it would be possible to control the share price for quite some time. The odds of 5/4 in depressing the share price helps counteract the effect of non-proven financial news and LT buying. There is of course no proof and no accusation, it is merely one supposition among many that this may be being carried out internal or external to the company, however any question of a MBO would surely back up my suspicions. |
Posted at 11/9/2007 17:11 by mad mike Someone, asked about my view on the share price.I don't lean towards manipulation theories. I'm coming around to the view (& I've seen it elsewhere e.g. TMC), that there are two big sustained rises for a small company having potential large future growth. First there is the rise, when first floated, where the ordinary PIs climb aboard in numbers, partly driven by ramping of the blue skies possibilities, by the pre-float PIs. Then some reality sets in, about real timescales, the number of obstacles that need to be overcome, which is sometimes coupled with failed promises of early profitability, or failure in operational execution becoming clear to the PIs. Also around this time there may need to be a change in strategy, or market focus, because everything wasn't thought through, or new obstacles occur, or markets change. This of course unsettles everyone. Inevitably the share prices then goes backwards (though not necessarily in a straight line). This state last for a 'few'(!) years. Then there is the second, substainable rise, but this requires the company to be proven to be profitable (i.e. not promises, or projections, but regulatory results). The company's business strategy also must be credible, with clear evidence that the startegy is actually working in practice (i.e. that future growth is likely to real, not an aim). Furthermore the company must be able to show operational excellence, so that it is clear that the people throughout the company are capable, and large enough to support existing and future growth. Plus, it is always important to have patents actually granted, not just applied for, as is often the case at float time. Finally there needs to be no important patent disputes/challenges. Once all those hurdles are crossed, and the management are credible, I believe the institutions are keen to buy in, particularly as they will see the share price is depressed, and the company is then a relatively low risk investment with high upside. But the company also needs a roadshow to tell the institutions. Only then does the share price re-rate, as the institutions buy in and make large profits from the depressed shareprice. It looks to me like Bioprogress/Meldex is getting increasing close to the trigger point that results in a re-rating. [edit: but will the interims, or the full year results be one of the necessary hurdles, before the trigger] However, if I had come to those conclusions before I first invested in Bioprogress/Meldex, then I would have held off investing until a few weeks ago! LOL!! So don't take any notice of me!! In the case of TMC (a miner), substitute the word patents with mining rights/certificates of extraction, and you have a similar story. The shareprice was depressed for years, despite the company sitting on the fourth biggest nickle resource in the world. Even as the company put all the bricks in the wall (lots of licenses/permits/cer |
Posted at 11/9/2007 15:31 by m5 MM, thanks for the post. Certainly made intersting reading and you may be right on the button.Like many I am quiet happy to stick with this share for the longer term but RT needs to address the share price situation PDQ. For those that say it is completely out of his hands I do not agree, and I understand from Marick that it is indeed in hand, it needs to be. Patience is wearing thin all round, and it is obvious that whatever strategy RT is employing very few seem to know about it, hence the lack of interest and general confidence in the share. What people don't know about they make up or just ignore, producing not always a positive outcome.What is your opinion of the current share price and its lethargy despite the positive news we have had over the past 6 months?. Do you feel that there has been any manipulation with the share price over that period? |
Posted at 11/9/2007 08:19 by nick2412 SC3 - thanks for your reply. There was some discussion on this thread by bracknell boy and others that speculated that J & J's Tylenol could be a candidate for a tabwrap deal. One single deal alone with a 3% royalty on such a product would put all foreseeable internal in-house projections into the shade.I reiterate that if you say the in-house products are the compelling reason to invest because BPRG's technology advantages will knock out the competition then you need to ask why won't TTP flock to the provider and patent holder of these disruptive technologies. Judging by the number of partners alluded to by BPRG they already are forming an orderly queue. That's even before Meldex begins to solve the global problem of counterfeit drugs with their professed superior technology. Of course if BPRG's technology isn't really up to much then the in-house products will struggle to take market share and there will be no partner deals whatsoever. So, yes, under this scenario your suggestion that TTP deals are not a significant reason to invest holds good. But I doubt if this is the reasoning behind the case you make. I don't think it's especially fruitful to get into the guessing game of weighted percentages although I am pleased you have moved up to 30% from 20% in terms of assessing the influence of external deals :-) Of course I can see in-house products being the more influential side of the business IF Meldex acquires a few more Mebrosin type companies by issuing truck loads of shares at 50P. We would then have the much quoted $1 billion company and an 'exhuberant' 45p to 60p share price for the next five years. It's what I fear from growth by acquisition companies. What RT has done has been admirable and essential but there is a time to pause and that time has been reached in my view. Building a great business is not always synonymous with building a great share price. With constant dilution invariably a lacklustre share price (as we have now) remains forever lacklustre. I want to see a halt to further acquisitions (and options) until the promised 'early fruits' are visible and shareholder value is delivered. I do think RT has done a great job in putting Meldex in a position where negotiations for third party deals can be conducted from a position of financial strength. In addition there is the useful negotiating stance of 'take it or leave it as we have the technology and infrastructure to go it alone and take market share from you if necessary'. I share and accept Inghu's view that ultimately Meldex could have the capabilities to put out in-house products for blockbuster markets. But the point being is that the stepping stones that leads the company there will be TTP third party royalty based deals for blockbuster markets. As I said before, this is not a self-induced pipedream but it's based on public domain company statements and broker notes from RT and associates over a protracted period of time. I think perhaps one explanation is that management have become obsessed with avoiding a share price spike and want to remove Meldex from the volatility and speculative nature of BPRG of old. Fair enough, but I think that is an unnecessary worry and is not in shareholders interests. You'll know the industry better than me but look at OXB, PTI and Silent Therapeutics. All had significant third party deals and the shares rocketed. Perhaps more importantly, the stock price stayed buoyant after the spikes. In the case of SLN the rise was a combination of spikes and a relentless northwards creep. That's the share price combination I'd like to see RT should aspire to rather than playing down prospective big external deals as a primary reason to invest! There is another worthy stock, Allergy Therapeutics, that has slowly but surely grown its internal revenues and profitability. It has also pursued going it alone and has raised significant sums of money. It also is tackling blockbuster markets. Does the market pay attention to the slow but steady growth from its in-house sales? Not at all, look at the graph, the market awaits the 'big deal' that allows the company to offer mass market commercial product after possible Phase 3 trial success. The difference between AGY to Meldex is that AGY is tied by clinical trials and has limited product line in terms of getting that deal that makes the share price motor. The fact is that significant deals will move stocks swiftly northwards. Almost invariably they start to move before a major deal. BPRG's stock price is stagnant so I suspect that the message which I take issue with of 'don't invest for big external deals' is half correct. I hope it is just a half completed sentence and just misses out 'because we are slightly late so need to dampen expectations for a few weeks.' Anyway, all the best and maybe I'll see you and DW at the EGM. |
Posted at 10/9/2007 19:31 by fatboy9 poorold - you said "I would not be surprised at all to find out a TabWrap System has been purchased by a global pharma either. I heard earlier this year that the next machine built would likely go that route." - strangely enough, this is a topic of conversation that I have been having offboard with several other investors. My question to the other investors and to you also, is does RT even have to tell us about the TTP ordering the machines until such time as commercialisation of a product because up until this point it will not have a material impact on the BPRG share price if the TTP has very deep pockets and can afford to pay for x machines out of their petty cash. FB9 |
Posted at 10/9/2007 19:25 by nick2412 Jan-mar - good to hear re. MBO. Just hope there is no other lowly priced takeover in the wings.I always enjoy the posts from Walrus and he makes some fair points. As for GH I think events would have progressed like this. GH would have raised about 10m from Collins Stewart at higher than the current share price. He'd have concluded deals with a few pharmas with accompanying share price spikes. The share price would at some stages go wildly higher and have a big trading range. The lows probably higher than the current share price. We'd have minimal revenues and there would be no sign of commercialisation from the 'big' deals. Think of Proctor and Gamble, Bristol Myers Squib/ Convatec, Boots, Wyeth, Perrigo etc etc. There would be high cash burn and GH would raise funds again. Not sure how long that cycle could go on for particularly if he needed new funds in the midst of a bear market. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
